The reverse transport of DA, what physiological significance?

[1]  S. Ross,et al.  Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro. , 2009, Acta pharmacologica et toxicologica.

[2]  S. Ross,et al.  BLOCKING ACTION OF SYMPATHOMIMETIC AMINES ON THE UPTAKE OF TRITIATED NORADRENALINE BY MOUSE CEREBRAL CORTEX TISSUES IN VITRO. , 2009, Acta pharmacologica et toxicologica.

[3]  U. Spampinato,et al.  The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used , 2000, Neuropharmacology.

[4]  E. Vizi.  Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. , 2000, Pharmacological reviews.

[5]  A. Gobert,et al.  The in vivo modulation of dopamine synthesis by calcium ions: influences on the calcium independent release , 1999, Neurochemistry International.

[6]  M. Yoshioka,et al.  Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex. , 1999, European journal of pharmacology.

[7]  J. Schulz,et al.  Malonate‐Induced Generation of Reactive Oxygen Species in Rat Strium Depends on Dopamine Release but Not on NMDA Receptor Activation , 1999, Journal of neurochemistry.

[8]  R. Pontcharraud,et al.  Lactic acid-induced increase of extracellular dopamine measured by microdialysis in rat striatum: evidence for glutamatergic and oxidative mechanisms , 1999, Brain Research.

[9]  J. Stamford,et al.  Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data , 1999, Brain Research.

[10]  J. Deniau,et al.  Three-dimensional distribution of nigrostriatal neurons in the rat: relation to the topography of striatonigral projections , 1999, Neuroscience.

[11]  R. Pontcharraud,et al.  Origin of extracellular dopamine increase induced by lactic acid striatal perfusion monitored by microdialysis in the awake rat. , 1999, Neuroreport.

[12]  U. Spampinato,et al.  Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study , 1999, Neuroscience.

[13]  G. Gerhardt,et al.  In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. , 1999, The Journal of pharmacology and experimental therapeutics.

[14]  R. L. Büyükuysal,et al.  Anoxia‐Induced Dopamine Release from Rat Striatal Slices , 1999, Journal of neurochemistry.

[15]  J. Stamford,et al.  Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia , 1999, Brain Research Bulletin.

[16]  P. Wong,et al.  Regulation of striatal dopamine release through 5‐HT1 and 5‐HT2 receptors , 1999 .

[17]  P. Fletcher,et al.  Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction , 1999, Psychopharmacology.

[18]  C. Meshul,et al.  Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion , 1999, Neuroscience.

[19]  M. Low,et al.  Dopamine D2 Receptor‐Deficient Mice Exhibit Decreased Dopamine Transporter Function but No Changes in Dopamine Release in Dorsal Striatum , 1999, Journal of neurochemistry.

[20]  Junxia Xie,et al.  Pharmacological characterisation of dopamine overflow in the striatum of the normal and MPTP-treated common marmoset, studied in vivo using fast cyclic voltammetry, nomifensine and sulpiride , 1998, Journal of Neuroscience Methods.

[21]  T. Chase,et al.  Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration , 1998, Brain Research.

[22]  A. Dart,et al.  Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms. , 1998, Journal of cardiovascular pharmacology.

[23]  E. Vizi.  Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release , 1998, Neurochemistry International.

[24]  G. Gerhardt,et al.  In VivoElectrochemical Studies of Dopamine Clearance in Subregions of Rat Nucleus Accumbens: Differential Properties of the Core and Shell , 1998, Experimental Neurology.

[25]  A. Piriou,et al.  Extracellular dopamine and catabolites in rat striatum during lactic acid perfusion as determined by in vivo microdialysis , 1998, Brain Research.

[26]  A. Lin,et al.  Role of dopamine uptake in NMDA-modulated K+-evoked dopamine overflow in rat striatum: an in vivo electrochemical study , 1998, Neuroscience Research.

[27]  Luigi F. Agnati,et al.  The emergence of the volume transmission concept 1 Published on the World Wide Web on 12 January 1998. 1 , 1998, Brain Research Reviews.

[28]  D. Dluzen,et al.  Inhibition of striatal dopamine transporter activity by 17beta-estradiol. , 1998, European journal of pharmacology.

[29]  J. Henry,et al.  The vesiicular monoamine transporter: from chromaffin granule to brain , 1998, Neurochemistry International.

[30]  S. Cragg,et al.  Dopamine is released spontaneously from developing midbrain neurons in organotypic culture , 1998, Neuroscience.

[31]  S. Hersch,et al.  Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra , 1997, The Journal of comparative neurology.

[32]  G. Gerhardt,et al.  Effects of ethanol on striatal dopamine overflow and clearance: an in vivo electrochemical study. , 1997, Alcohol.

[33]  M. Häusser,et al.  Intersynaptic diffusion of neurotransmitter. , 1997, Trends in neurosciences.

[34]  M. Gobbi,et al.  Carrier‐dependent and Ca2+‐dependent 5‐HT and dopamine release induced by (+)‐amphetamine, 3,4‐methylendioxy‐methamphetamine, p‐chloroamphetamine and (+)‐fenfluramine , 1997, British journal of pharmacology.

[35]  P. Garris,et al.  Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals , 1997, Brain Research.

[36]  K. Hoyt,et al.  Mechanisms of Dopamine-Induced Cell Death in Cultured Rat Forebrain Neurons: Interactions with and Differences from Glutamate-Induced Cell Death , 1997, Experimental Neurology.

[37]  S. Cragg,et al.  Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. , 1997, Journal of neurophysiology.

[38]  S. Cragg,et al.  Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. , 1997, Journal of neurophysiology.

[39]  L. Descarries,et al.  Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: A quantitative autoradiographic and immunocytochemical analysis , 1996, The Journal of comparative neurology.

[40]  J. B. Justice,et al.  Regulation of dopamine uptake in rat striatal tissue by NMDA receptors as measured using rotating disk electrode voltammetry , 1996, Neuroscience Letters.

[41]  M. Zigmond,et al.  Modification of Dopamine Transporter Function: Effect of Reactive Oxygen Species and Dopamine , 1996, Journal of neurochemistry.

[42]  C. Cotman,et al.  Dopaminergic denervation of striatum results in elevated expression of NR2A subunit. , 1996, Neuroreport.

[43]  A. Carvalho,et al.  Relationships between ATP depletion, membrane potential, and the release of neurotransmitters in rat nerve terminals. An in vitro study under conditions that mimic anoxia, hypoglycemia, and ischemia. , 1996, Stroke.

[44]  E. Vizi,et al.  Effect of hypoxia and glucose deprivation on ATP level, adenylate energy charge and [Ca2+]0-dependent and independent release of [3H]dopamine in rat striatal slices , 1996, Neurochemistry International.

[45]  M. Zigmond,et al.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Z. Kruk,et al.  Real‐Time Effects of N‐Methyl‐d‐Aspartic Acid on Dopamine Release in Slices of Rat Caudate Putamen: A Study Using Fast Cyclic Voltammetry , 1996, Journal of neurochemistry.

[47]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[48]  M. Zigmond,et al.  Increased Neostriatal Tyrosine Hydroxylation During Stress: Role of Extracellular Dopamine and Excitatory Amino Acids , 1996, Journal of neurochemistry.

[49]  W. Schultz,et al.  Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli , 1996, Nature.

[50]  John L. Hudson,et al.  In Vivo Electrochemical Studies of Dopamine Overflow and Clearance in the Striatum of Normal and MPTP‐Treated Rhesus Monkeys , 1996, Journal of neurochemistry.

[51]  M. Kuhar,et al.  The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  K. Chergui,et al.  Uptake of Dopamine Released by Impulse Flow in the Rat Mesolimbic and Striatal Systems In Vivo , 1995, Journal of neurochemistry.

[53]  A. Lin,et al.  Dynamic analysis of ethanol effects on NMDA-evoked dopamine overflow in rat striatum , 1995, Brain Research.

[54]  R. Bartrons,et al.  Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats , 1995, Brain Research.

[55]  V. Olivier,et al.  Direct in vivo comparison of two mechanisms releasing dopamine in the rat striatum , 1995, Brain Research.

[56]  C. Pasqualini,et al.  Acute Stimulatory Effect of Estradiol on Striatal Dopamine Synthesis , 1995, Journal of neurochemistry.

[57]  Bert Sakmann,et al.  Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons , 1995, Neuron.

[58]  M. Le Moal,et al.  d‐Fenfluramine Increases Striatal Extracellular Dopamine In Vivo Independently of Serotonergic Terminals or Dopamine Uptake Sites , 1995, Journal of neurochemistry.

[59]  E. Abercrombie,et al.  Biochemistry of Somatodendritic Dopamine Release in Substantia Nigra: An In Vivo Comparison with Striatal Dopamine Release , 1995, Journal of neurochemistry.

[60]  D. Reich,et al.  Nitric Oxide Modulates Dopamine Release During Global Temporary Cerebral Ischemia , 1995, Anesthesia and analgesia.

[61]  B. Madras,et al.  [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum. , 1995, Journal of Pharmacology and Experimental Therapeutics.

[62]  D. Sulzer,et al.  Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[63]  J. Bennett,et al.  NMDA Receptor Blockade Increases In Vivo Striatal Dopamine Synthesis and Release in Rats and Mice with Incomplete, Dopamine‐Depleting, Nigrostriatal Lesions , 1995, Journal of neurochemistry.

[64]  Y. Eun,et al.  Ca2+‐DEPENDENT AND ‐INDEPENDENT MECHANISMS OF ISCHAEMIA‐EVOKED RELEASE OF [3H]‐DOPAMINE FROM RAT STRIATAL SLICES , 1995, Clinical and experimental pharmacology & physiology.

[65]  J. Glowinski,et al.  Effects of Arachidonic Acid on Dopamine Synthesis, Spontaneous Release, and Uptake in Striatal Synaptosomes from the Rat , 1995, Journal of neurochemistry.

[66]  U. Spampinato,et al.  Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat , 1995, Neuropharmacology.

[67]  S. Hersch,et al.  The dopamine transporter: immunochemical characterization and localization in brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[68]  Shigenori Watanabe,et al.  Effects of transient forebrain ischemia on long-term enhancement of dopamine release in rat striatal slices , 1995, Brain Research.

[69]  G. Gerhardt,et al.  Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions , 1995, Neuroscience Letters.

[70]  B. Ghetti,et al.  Dopamine Transporter‐Dependent and ‐Independent Endogenous Dopamine Release from Weaver Mouse Striatum In Vitro , 1995, Journal of neurochemistry.

[71]  K. Johnson,et al.  Inhibitory Effects of Nitric Oxide on the Uptake of [3H]Dopamine and [3H]Glutamate by Striatal Synaptosomes , 1994, Journal of neurochemistry.

[72]  P. Garris,et al.  Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[73]  Z. Kruk,et al.  A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in the rat brain slice , 1994, Brain Research.

[74]  G. Yadid,et al.  Endogenous serotonin stimulates striatal dopamine release in conscious rats. , 1994, The Journal of pharmacology and experimental therapeutics.

[75]  S. Z. Lin,et al.  Restoration of dopamine overflow and clearance from the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal mesencephalic grafts. , 1994, The Journal of pharmacology and experimental therapeutics.

[76]  G. Gerhardt,et al.  Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake , 1994, Neuroscience Letters.

[77]  G. Uhl,et al.  Phorbol esters alter functions of the expressed dopamine transporter. , 1994, European journal of pharmacology.

[78]  R. Rosenthal,et al.  Increased Activation of L‐Type Voltage‐Dependent Calcium Channels Is Associated with Glycine Enhancement of N‐Methyl‐d‐Aspartate‐Stimulated Dopamine Release in Global Cerebral Ischemia/Reperfusion , 1994, Journal of neurochemistry.

[79]  J. Penney,et al.  Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions , 1994, Brain Research.

[80]  M. Kuhar,et al.  Nitric oxide inhibits [3H]dopamine uptake , 1994, Brain Research.

[81]  J. Desce,et al.  Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes , 1994, Brain Research.

[82]  C. Pasqualini,et al.  Evidence for Protein Kinase C Involvement in the Short‐Term Activation by Prolactin of Tyrosine Hydroxylase in Tuberoinfundibular Dopaminergic Neurons , 1994, Journal of neurochemistry.

[83]  B. Sakmann,et al.  Active propagation of somatic action potentials into neocortical pyramidal cell dendrites , 1994, Nature.

[84]  G. Rudnick,et al.  Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. , 1993, Molecular pharmacology.

[85]  M. Raiteri,et al.  Carrier-mediated release of neurotransmitters , 1993, Trends in Neurosciences.

[86]  S. D. Glick,et al.  Sex differences in ethanol-induced dopamine release in nucleus accumbens and in ethanol consumption in rats. , 1993, Alcoholism, clinical and experimental research.

[87]  Boris Barbour,et al.  Nonvesicular release of neurotransmitter , 1993, Neuron.

[88]  G. Gerhardt,et al.  In Vivo Electrochemical Measurements of Exogenous Dopamine Clearance in Normal and Neonatal 6-Hydroxydopamine-Treated Rat Striatum , 1993, Experimental Neurology.

[89]  J. O. Schenk,et al.  D2 Receptors May Modulate the Function of the Striatal Transporter for Dopamine: Kinetic Evidence from Studies In Vitro and In Vivo , 1993, Journal of neurochemistry.

[90]  C. Pasqualini,et al.  Short‐Term Inhibitory Effect of Estradiol on Tyrosine Hydroxylase Activity in Tuberoinfundibular Dopaminergic Neurons In Vitro , 1993, Journal of neurochemistry.

[91]  P Bach-y-Rita,et al.  Neurotransmission in the brain by diffusion through the extracellular fluid: a review , 1993, Neuroreport.

[92]  M. Galloway,et al.  Serotonin-facilitated dopamine release in vivo: pharmacological characterization. , 1993, The Journal of pharmacology and experimental therapeutics.

[93]  D. Sulzer,et al.  Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons , 1993, Journal of neurochemistry.

[94]  M. Caron,et al.  Molecular characterization of the dopamine transporter. , 1993, Trends in pharmacological sciences.

[95]  J. Townsend,et al.  Pre- and Postsynaptic Neurotoxic Effects of Dopamine Demonstrated by Intrastriatal Injection , 1993, Experimental Neurology.

[96]  L. Parsons,et al.  Co‐Administration of the D2 Antagonist Pimozide Inhibits Up‐Regulation of Dopamine Release and Uptake Induced by Repeated Cocaine , 1993, Journal of neurochemistry.

[97]  S. Bernáth.  Calcium-independent release of amino acid neurotransmitters: Fact or artifact? , 1992, Progress in Neurobiology.

[98]  J. Marshall,et al.  Elevated NMDA receptors in parkinsonian striatum. , 1992, Neuroreport.

[99]  R. Gonzales,et al.  Alcohol inhibition of NMDA-stimulated catecholamine efflux in aging brain. , 1992, Alcohol.

[100]  K. Ikeda,et al.  Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease , 1992, Neuroscience Letters.

[101]  F I Carroll,et al.  High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain , 1992, Synapse.

[102]  A. Lajtha,et al.  Regulatory Interactions Among Axon Terminals Affecting the Release of Different Transmitters from Rat Striatal Slices Under Hypoxic and Hypoglycemic Conditions , 1992, Journal of neurochemistry.

[103]  H. Jacocks,et al.  Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. , 1992, The Journal of pharmacology and experimental therapeutics.

[104]  B. Rajanna,et al.  The effects of cadmium in vitro on adenosine triphosphatase system and protection by thiol reagents in rat brain microsomes , 1992, Archives of environmental contamination and toxicology.

[105]  G. Uhl,et al.  Expression of a single dopamine transporter cDNA can confer two cocaine binding sites , 1992, Neuroreport.

[106]  G. Rudnick,et al.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[107]  J. Desce,et al.  l-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-d-aspartate receptors , 1992, Neuroscience.

[108]  E. Abercrombie,et al.  Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input , 1992, Neuroscience.

[109]  V. Ádám‐Vizi.  External Ca2+‐Independent Release of Neurotransmitters , 1992, Journal of neurochemistry.

[110]  A. Gobert,et al.  GnRH‐Associated peptide (GAP) is present in the rat striatum and affects the synthesis and release of dopamine , 1992, Journal of neuroscience research.

[111]  M. Fujishima,et al.  Inhibition of Ischemia‐Induced Dopamine Release by ω‐Conotoxin, a Calcium Channel Blocker, in the Striatum of Spontaneously Hypertensive Rats: In Vivo Brain Dialysis Study , 1992, Journal of neurochemistry.

[112]  T. Gotow,et al.  Cytoplasmic architecture of the axon terminal: Filamentous strands specifically associated with synaptic vesicles , 1991, Neuroscience.

[113]  A. Grace.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[114]  E. Lábos,et al.  Non-synaptic interactions at presynaptic level , 1991, Progress in Neurobiology.

[115]  B. Ghetti,et al.  In Vitro Release of Endogenous Dopamine from the Striatum of the Weaver Mutant Mouse , 1991, Journal of neurochemistry.

[116]  J. Brodkin,et al.  Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. , 1991, The Journal of pharmacology and experimental therapeutics.

[117]  G. Uhl,et al.  Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. , 1991, Science.

[118]  B. Westerink,et al.  Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats , 1991, Journal of neurochemistry.

[119]  H. Nissbrandt,et al.  Reserpine-insensitive dopamine release in the substantia nigra? , 1991, Brain Research.

[120]  K. Krueger.  Steroids and neuronal activity (Ciba foundation symposium 153) edited by Derek Chadwick and Kate Widdows, John Wiley & Sons, 1990. £35.95 (x + 284 pages) ISBN 0 471 92689 2 , 1991, Trends in Neurosciences.

[121]  S. Yi,et al.  Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes. , 1991, European journal of pharmacology.

[122]  E. D. De Souza,et al.  Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. , 1991, The Journal of pharmacology and experimental therapeutics.

[123]  C. Blaha,et al.  Biphasic striatal dopamine release during transient ischemia and reperfusion in gerbils. , 1991, Stroke.

[124]  M. Zigmond,et al.  High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. , 1991, The Journal of pharmacology and experimental therapeutics.

[125]  P. Kalivas,et al.  A Comparison of Axonal and Somatodendritic Dopamine Release Using In Vivo Dialysis , 1991, Journal of neurochemistry.

[126]  G. Paxinos,et al.  Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography , 1991, The Journal of comparative neurology.

[127]  A. Lajtha,et al.  Carrier‐mediated efflux of [3H] dopamine and [3H]1‐methyl‐4‐phenylopyridine: Effects of ascorbic acid , 1991, Synapse.

[128]  R. Baldessarini,et al.  Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine , 1991, Neuropharmacology.

[129]  A. Gobert,et al.  The glutamate-mediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function , 1990, Neuroscience.

[130]  D. Sulzer,et al.  Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action , 1990, Neuron.

[131]  P. Soares-da-Silva,et al.  Overflow of endogenous dopamine and 3,4-dihydroxyphenylacetic acid from tissues of the rat brain, elicited by electrical stimulation, depolarization by potassium and activation of carrier-mediated release , 1990, Neuropharmacology.

[132]  J. Hollerman,et al.  The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons , 1990, Brain Research.

[133]  B. Rajanna,et al.  Effects of cadmium and mercury on Na(+)-K+, ATPase and uptake of 3H-dopamine in rat brain synaptosomes. , 1990, Archives internationales de physiologie et de biochimie.

[134]  A. Ewing,et al.  Dopamine concentration in the cytoplasmic compartment of single neurons determined by capillary electrophoresis , 1990, Journal of Neuroscience Methods.

[135]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[136]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[137]  R. Roth,et al.  Effect ofl-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies , 1990, Brain Research.

[138]  G. Arbuthnott,et al.  In Vivo Mechanisms Underlying Dopamine Release from Rat Nigrostriatal Terminals: II. Studies Using Potassium and Tyramine , 1990, Journal of neurochemistry.

[139]  A. Nieoullon,et al.  Localization of N‐Methyl‐d‐Aspartate Receptors in the Rat Striatum: Effects of Specific Lesions on the [3H]3‐(2‐Carboxypiperazin‐4‐yl)propyl‐1‐Phosphonic Acid Binding , 1990, Journal of neurochemistry.

[140]  G. Snyder,et al.  Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. , 1990, The Journal of pharmacology and experimental therapeutics.

[141]  R. Wightman,et al.  Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake , 1990, Brain Research Reviews.

[142]  D. Segal,et al.  Apomorphine Does Not Alter Amphetamine‐Induced Dopamine Release Measured in Striatal Dialysates , 1990, Journal of neurochemistry.

[143]  R. Elde,et al.  Monoamine synaptic structure and localization in the central nervous system. , 1990, Journal of electron microscopy technique.

[144]  J. Commissiong,et al.  Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle , 1990, British journal of pharmacology.

[145]  A. Graybiel,et al.  Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. II. High affinity uptake sites for dopamine , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[146]  K. Mine,et al.  The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes. , 1990, The Journal of pharmacology and experimental therapeutics.

[147]  J. Woodward,et al.  Ethanol Inhibition of N‐Methyl‐D‐Aspartate‐Stimulated Endogenous Dopamine Release from Rat Striatal Slices: Reversal by Glycine , 1990, Journal of neurochemistry.

[148]  A. Ewing,et al.  Estimation of Free Dopamine in the Cytoplasm of the Giant Dopamine Cell of Planorbis corneus by Voltammetry and Capillary Electrophoresis , 1990, Journal of neurochemistry.

[149]  R. Zaczek,et al.  Intrasynaptosomal Sequestration of [3H]Amphetamine and [3H]Methylenedioxyamphetamine: Characterization Suggests the Presence of a Factor Responsible for Maintaining Sequestration , 1990, Journal of neurochemistry.

[150]  A. Gobert,et al.  Direct observation of dopamine compartmentation in striatal nerve terminal by ‘in vivo’ measurement of the specific activity of released dopamine , 1989, Brain Research.

[151]  L. Agnati,et al.  Transient forebrain ischemia produces multiple deficits in dopamine D1 transmission in the lateral neostriatum of the rat , 1989, Brain Research.

[152]  R. Wightman,et al.  Effects of D‐2 Antagonists on Frequency‐Dependent Stimulated Dopamine Overflow in Nucleus Accumbens and Caudate‐Putamen , 1989, Journal of neurochemistry.

[153]  C. J. Schmidt,et al.  The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine. , 1989, European journal of pharmacology.

[154]  U. Ungerstedt,et al.  Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. , 1989, European journal of pharmacology.

[155]  U. Ungerstedt,et al.  In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. , 1989, European journal of pharmacology.

[156]  D. Nicholls,et al.  Glutamate Release from Guinea‐Pig Synaptosomes: Stimulation by Reuptake‐Induced Depolarization , 1989, Journal of neurochemistry.

[157]  H. L. Wiener,et al.  Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier. , 1989, European journal of pharmacology.

[158]  B. Westerink,et al.  Effect of Ouabain Applied by Intrastriatal Microdialysis on the In Vivo Release of Dopamine, Acetylcholine, and Amino Acids in the Brain of Conscious Rats , 1989, Journal of neurochemistry.

[159]  K. Jhamandas,et al.  Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. , 1989, The Journal of pharmacology and experimental therapeutics.

[160]  L. Cubeddu,et al.  Effects of low extracellular chloride on dopamine release and the dopamine transporter. , 1989, The Journal of pharmacology and experimental therapeutics.

[161]  C. Altar,et al.  Preservation of dopamine release in the denervated striatum , 1989, Neuroscience Letters.

[162]  R. Llinás.  The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. , 1988, Science.

[163]  Y. Agid,et al.  [3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy. , 1988, European journal of pharmacology.

[164]  J. Engel,et al.  Ethanol enhances the calcium-dependent stimulus-induced release of endogenous dopamine from slices of rat striatum and nucleus accumbens in vitro , 1988, Neuropharmacology.

[165]  H. Tilson,et al.  Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage , 1988, Brain Research.

[166]  J. B. Justice,et al.  Effects of cocaine on release and uptake of dopamine in vivo: Differentiation by mathematical modeling , 1988, Pharmacology Biochemistry and Behavior.

[167]  R. Busto,et al.  Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia , 1988, Neuroscience Letters.

[168]  A. Schomig,et al.  Neuronal sodium homoeostatis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart. , 1988, Circulation research.

[169]  Ian Q. Whishaw,et al.  Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats , 1988, Brain Research.

[170]  R. M. Wightman,et al.  Real-time characterization of dopamine overflow and uptake in the rat striatum , 1988, Neuroscience.

[171]  L. Cubeddu,et al.  Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. , 1988, The Journal of pharmacology and experimental therapeutics.

[172]  G. Arbuthnott,et al.  Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.

[173]  S. Sikdar,et al.  In vivo studies on the dopamine re-uptake mechanism in the striatum of the rat: Effects of benztropine, sodium and ouabain , 1988, Brain Research.

[174]  D. Agoston,et al.  The synaptic vesicle and the cytoskeleton. , 1987, The Biochemical journal.

[175]  Dennis P. Nelson,et al.  Ammonia‐Induced Release of Neurotransmitters from Rat Brain Synaptosomes: Differences Between the Effects on Amines and Amino Acids , 1987, Journal of neurochemistry.

[176]  J. B. Justice,et al.  Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation , 1987, Brain Research.

[177]  M. Zigmond,et al.  Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[178]  B. Guibert,et al.  Involvement of intraterminal dopamine compartments in the amine release in the cat striatum , 1987, Neuroscience Letters.

[179]  M. Raiteri,et al.  Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain , 1987, British journal of pharmacology.

[180]  L. Cubeddu,et al.  Ionic mechanism of dopaminergic and muscarinic auto- and heteroreceptor activation in superfused striatal slices: role of extracellular chloride. , 1987, Journal of Pharmacology and Experimental Therapeutics.

[181]  A. Schömig,et al.  Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. , 1987, Circulation research.

[182]  W. Schultz.  Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. , 1986, Journal of neurophysiology.

[183]  L. Cubeddu,et al.  Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. , 1986, The Journal of pharmacology and experimental therapeutics.

[184]  H. Maker,et al.  Amine-mediated toxicity The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the rat , 1986, Neuropharmacology.

[185]  Georg W. Kreutzberg,et al.  The significance of dendritic release of transmitter and protein in the substantia nigra , 1985, Neurochemistry International.

[186]  T. Cunnane.  Non-synaptic Interactions Between Neurons: Modulation of Neurochemical Transmission by E. Sylvester Vizi, John Wiley & Sons, 1984. £22.50 (xiii + 260 pages) ISBN 0 471 90378 7 , 1985, Trends in Neurosciences.

[187]  S. Greenfield.  The significance of dendritic release of transmitter and protein in the substantia nigra , 1985, Neurochemistry International.

[188]  H. Herdon,et al.  Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: Effects of depolarizing stimuli, amphetamine and synthesis inhibition , 1985, Brain Research.

[189]  A. Carlsson,et al.  Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra , 1985, The Journal of pharmacy and pharmacology.

[190]  K. Sweadner.  Ouabain-evoked norepinephrine release from intact rat sympathetic neurons: evidence for carrier-mediated release , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[191]  R. Wightman,et al.  Amphetamine attenuates the stimulated release of dopamine in vivo. , 1985, The Journal of pharmacology and experimental therapeutics.

[192]  J. Cooper,et al.  Possible mechanisms involved in the release and modulation of release of neuroactive agents , 1984, Neurochemistry International.

[193]  A. Schomig,et al.  Release of Endogenous Catecholamines in the Ischemic Myocardium of the Rat: Part A Locally Mediated Release , 1984, Circulation research.

[194]  A. Schomig,et al.  Release of Endogenous Catecholamines in the Ischemic Myocardium of the Rat: Part B Effect of Sympathetic Nerve Stimulation , 1984, Circulation research.

[195]  R. Wightman,et al.  Striatal dopamine uptake in the rat: In vivo analysis by fast cyclic voltammetry , 1984, Neuroscience Letters.

[196]  J. Costentin,et al.  Simultaneous evaluation by a double labelling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum. , 1984, Biochemical pharmacology.

[197]  R. Llinás,et al.  Electrophysiology of pars compacta cells in the in vitro substantia nigra—a possible mechanism for dendritic release , 1984, Brain Research.

[198]  A. C. Collins,et al.  Effects of ethanol and salsolinol on catecholamine function in LS and SS mice , 1984, Pharmacology Biochemistry and Behavior.

[199]  S. Philips,et al.  In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine , 1983, Neuropharmacology.

[200]  A. Galzin,et al.  Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate. , 1983, The Journal of pharmacology and experimental therapeutics.

[201]  A. Cuello.  Nonclassical neuronal communications. , 1983, Federation proceedings.

[202]  J. Elghozi,et al.  Nomifensine antagonizes the ouabain-induced increase in dopamine metabolites in cerebrospinal fluid of the rat. , 1983, European journal of pharmacology.

[203]  M. Lynch,et al.  Possible association of alcohol tolerance with increased synaptic Ca2+ sensitivity , 1983, Nature.

[204]  H. Schoemaker,et al.  Dopamine Uptake by Rat Striatal Synaptosomes: A Compartmental Analysis , 1983, Journal of neurochemistry.

[205]  P. Groves.  A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement , 1983, Brain Research Reviews.

[206]  N. Uretsky,et al.  The importance of calcium in the amphetamine-induced stimulation of dopamine synthesis in mouse striata in vivo. , 1982, The Journal of pharmacology and experimental therapeutics.

[207]  C. Rutledge,et al.  Evidence for carrier-mediated efflux of dopamine from corpus striatum. , 1982, Biochemical pharmacology.

[208]  L. Tauc.  Non vesicular release of neurotransmitter. , 1982, Physiological reviews.

[209]  M. Erecińska,et al.  Neurotransmitter Metabolism in Rat Brain Synaptosomes: Effect of Anoxia and pH , 1982, Journal of neurochemistry.

[210]  P. A. Shore,et al.  Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine. , 1982, European journal of pharmacology.

[211]  D. Reis,et al.  Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum , 1981, Brain Research.

[212]  C. Sotelo,et al.  Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration , 1981, Neuroscience.

[213]  S. Z. Langer,et al.  Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine. , 1981, The Journal of pharmacology and experimental therapeutics.

[214]  J. Glowinski,et al.  Dendritic release of dopamine in the substantia nigra , 1981, Nature.

[215]  D. German,et al.  Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. , 1980, Biochemical pharmacology.

[216]  N. Uretsky,et al.  The Relationship Between the Stimulation of Dopamine Synthesis and Release Produced by Amphetamine and High Potassium in Striatal Slices , 1980, Journal of neurochemistry.

[217]  R. Wurtman,et al.  Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization , 1980, Brain Research.

[218]  W. Schultz,et al.  Dopaminergic activation of reticulata neurones in the substantia nigra , 1980, Nature.

[219]  D. Clarke,et al.  In vivo monoamine oxidase inhibition by d-amphetamine. , 1980, Biochemical pharmacology.

[220]  L. Descarries,et al.  Dopaminergic nerve endings visualised by high-resolution autoradiography in adult rat neostriatum , 1980, Nature.

[221]  J. Glowinski,et al.  Role of the dendritic release of dopamine in the reciprocal control of the two nigro-striatal dopaminergic pathways , 1979, Nature.

[222]  J. Raynaud,et al.  Dopamine uptake inhibitors and releasing agents differentiated by the use of synaptosomes and field-stimulated brain slices in vitro. , 1979, Biochemical pharmacology.

[223]  P. Roberts,et al.  STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS , 1979, Journal of neurochemistry.

[224]  M. M. Roberts,et al.  Amphetamine- and phenylethylamine-induced alterations in dopamine synthesis regulation in rat brain striatal synaptosomes. , 1979, The Journal of pharmacology and experimental therapeutics.

[225]  S. R. Snodgrass,et al.  EFFECT OF DIVALENT CATIONS ON THE AMPHETAMINE‐INDUCED STIMULATION OF [3H]CATECHOL SYNTHESIS IN THE STRIATUM 1 , 1979, Journal of neurochemistry.

[226]  A. Cho,et al.  Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. , 1979, The Journal of pharmacology and experimental therapeutics.

[227]  M. Raiteri,et al.  Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. , 1979, The Journal of pharmacology and experimental therapeutics.

[228]  N. Sharif,et al.  Effects ofl-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices , 1978, Brain Research.

[229]  A. Beaudet,et al.  The monoamine innervation of rat cerebral cortex: Synaptic and nonsynaptic axon terminals , 1978, Neuroscience.

[230]  Y. Agid,et al.  Dopaminergic nerve endings in the neostriatum of the rat—1. Identification by intracerebral injections of 5-hydroxydopamine , 1978, Neuroscience.

[231]  Y. Agid,et al.  Dopaminergic nerve endings in the neostriatum of the rat—2. Radioautographic study following local micro-injections of tritiated dopamine , 1978, Neuroscience.

[232]  K. Dismukes.  New look at the aminergic nervous system , 1977, Nature.

[233]  M. Kemel,et al.  Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices , 1977, Neuroscience Letters.

[234]  S. R. Snodgrass,et al.  Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices. , 1977, The Journal of pharmacology and experimental therapeutics.

[235]  P. Molinoff,et al.  The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. , 1977, The Journal of pharmacology and experimental therapeutics.

[236]  M. Raiteri,et al.  Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes. , 1977, Molecular pharmacology.

[237]  M. Zigmond,et al.  DOPAMINE BIOSYNTHESIS FROM L‐TYROSINE AND L‐PHENYLALANINE IN RAT BRAIN SYNAPTOSOMES: PREFERENTIAL USE OF NEWLY ACCUMULATED PRECURSORS 1, 2 , 1977, Journal of neurochemistry.

[238]  U. Schacht,et al.  Studies on brain metabolism of biogenic amines. , 1977, British journal of clinical pharmacology.

[239]  J. Glowinski,et al.  Release of dopamine in vivo from cat substantia nigra , 1977, Nature.

[240]  P. Spano,et al.  CHANGES IN SPECIFIC ACTIVITY OF DOPAMINE METABOLITES AS EVIDENCE OF A MULTIPLE COMPARTMENTATION OF DOPAMINE IN STRIATAL NEURONS , 1977, Journal of neurochemistry.

[241]  P. Baumann,et al.  Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments? , 1976, Nature.

[242]  J. Glowinski,et al.  Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with ‘autoreceptors’? , 1976, FEBS letters.

[243]  J. Kebabian,et al.  Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites. , 1976, Science.

[244]  Laurent Descarries,et al.  Quantitative data on serotonin nerve terminals in adult rat neocortex , 1976, Brain Research.

[245]  O. Phillipson,et al.  Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase , 1976, Nature.

[246]  A. Arnold,et al.  RECURRENT HORMONE DEPENDENT CHOREA: EFFECTS OF OESTROGENS AND PROGESTOGENS , 1976, Clinical endocrinology.

[247]  R. Vollmer.  Reviews of neuroscience , 1976 .

[248]  T. Jessell,et al.  Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.

[249]  R. Roth,et al.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. , 1976, European journal of pharmacology.

[250]  S J Young,et al.  Self-inhibition by dopaminergic neurons , 1975, Science.

[251]  M. Moskowitz,et al.  Brain H3‐catecholamine metabolism in experimental cerebral ischemia , 1975, Neurology.

[252]  K. E. Moore,et al.  D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. , 1975, The Journal of pharmacology and experimental therapeutics.

[253]  R. Kuczenski.  Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: Multiple pools of dopamine or multiple forms of tyrosine hydroxylase? , 1975, Neuropharmacology.

[254]  O. Lindvall,et al.  Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals , 1975, Brain Research.

[255]  V. Tennyson,et al.  5-Hydroxydopamine 'tagged' neuronal boutons in rabbit neostriatum: interrelationship between vesicles and axonal membrane. , 1974, Brain research.

[256]  J. Raynaud,et al.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum , 1974, The Journal of pharmacy and pharmacology.

[257]  A. Azzaro,et al.  The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue. , 1974, The Journal of pharmacology and experimental therapeutics.

[258]  D. Paton.  Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria , 1973, British journal of pharmacology.

[259]  Y. Agid,et al.  Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. , 1973, Nature: New biology.

[260]  R. Roth,et al.  Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. , 1973, Nature: New biology.

[261]  D. Paton.  Evidence for carrier‐mediated efflux of noradrenaline from the axoplasm of adrenergic nerves in rabbit atria , 1973, The Journal of pharmacy and pharmacology.

[262]  A. Horn.  Structure‐activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates , 1973, British journal of pharmacology.

[263]  A. Azzaro,et al.  Characteristics of amphetamine-induced release of norepinephrine from rat cerebral cortex in vitro. , 1972, The Journal of pharmacology and experimental therapeutics.

[264]  C. Sotelo.  The fine structural localization of norepinephrine- 3 H in the substantia nigra and area postrema of the rat. An autoradiographic study. , 1971, Journal of ultrastructure research.

[265]  C. Rutledge.  The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain. , 1970, The Journal of pharmacology and experimental therapeutics.

[266]  H. Thoenen,et al.  Cation dependence of the noradrenaline-releasing action of tyramine. , 1969, European journal of pharmacology.

[267]  M. Besson,et al.  Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[268]  B. Brodie,et al.  The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices. , 1969, The Journal of pharmacology and experimental therapeutics.

[269]  U. Ungerstedt,et al.  Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine. , 1968, European journal of pharmacology.

[270]  G. Breese,et al.  Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. , 1968, The Journal of pharmacology and experimental therapeutics.

[271]  G. Sedvall,et al.  The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. , 1968, The Journal of pharmacology and experimental therapeutics.

[272]  S. Udenfriend,et al.  A kinetic study of bovine adrenal tyrosine hydroxylase. , 1966, The Journal of biological chemistry.

[273]  L. Iversen,et al.  Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. , 1966, The Journal of pharmacology and experimental therapeutics.

[274]  S. Udenfriend,et al.  Inhibitors of purified beef adrenal tyrosine hydroxylase. , 1965, Biochemical pharmacology.

[275]  J. Glowinski,et al.  METABOLISM OF [3H]NOREPINEPHRINE IN THE RAT BRAIN , 1965, Journal of neurochemistry.

[276]  S. Udenfriend,et al.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.

[277]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.

[278]  G. Gerhardt,et al.  Voltage-dependency of the dopamine transporter in rat brain. , 1998, Advances in pharmacology.

[279]  E. Vizi,et al.  Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions , 1998, Hippocampus.

[280]  D. Standaert,et al.  Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation. , 1996, The Journal of pharmacology and experimental therapeutics.

[281]  V. Olivier,et al.  The Role of Calcium Ions in Dopamine Synthesis and Dopamine Release , 1994 .

[282]  H. Niznik,et al.  Dopamine receptors and transporters : pharmacology, structure, and function , 1994 .

[283]  G. Percheron,et al.  The Basal Ganglia IV , 1994, Advances in Behavioral Biology.

[284]  M. Fillenz,et al.  Short-term control of transmitter synthesis in central catecholaminergic neurones. , 1993, Progress in biophysics and molecular biology.

[285]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[286]  A. Gobert,et al.  Specifically Evoked Release of Newly Synthesized or Stored Dopamine by Different Treatments , 1991 .

[287]  Micaela Morelli,et al.  The Basal Ganglia III , 1991, Advances in Behavioral Biology.

[288]  J. Glowinski,et al.  In vitro effects of 17 beta-oestradiol on the sensitivity of receptors coupled to adenylate cyclase on striatal neurons in primary culture. , 1990, Ciba Foundation symposium.

[289]  G. Arbuthnott,et al.  Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis. , 1990, Pharmacology & therapeutics.

[290]  U. Ungerstedt,et al.  Influence of a carrier transport process on in vivo release and metabolism of dopamine: dependence on extracellular Na+. , 1989, Life sciences.

[291]  M. Zigmond,et al.  Animal models of parkinsonism using selective neurotoxins: clinical and basic implications. , 1989, International review of neurobiology.

[292]  A. Lajtha,et al.  Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine. , 1988, Life sciences.

[293]  R. Johnson,et al.  Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. , 1988, Physiological reviews.

[294]  S. Iversen,et al.  Handbook of Psychopharmacology , 1988, Springer US.

[295]  A. Lajtha,et al.  Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]Dopamine, and [14C]GABA , 1987, Journal of neuroscience research.

[296]  M. Eldefrawi,et al.  High affinity stereospecific binding of [3H] cocaine in striatum and its relationship to the dopamine transporter. , 1987, Membrane biochemistry.

[297]  P. Chrétien,et al.  Striatal dopamine does not appear involved in the voluntary intake of ethanol by rats. , 1986, Alcohol.

[298]  E. Vizi,et al.  Transmitter release from the cytoplasm is of physiological importance but not subject to presynaptic modulation. , 1986, Journal of Physiology.

[299]  L. Cubeddu,et al.  Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. , 1986, The Journal of pharmacology and experimental therapeutics.

[300]  W. Pulsinelli.  Selective neuronal vulnerability: morphological and molecular characteristics. , 1985, Progress in brain research.

[301]  D. Dluzen,et al.  Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: in vitro and in vivo studies. , 1985, Recent progress in hormone research.

[302]  B. Uvnäs,et al.  Cation exchange--a common mechanism in the storage and release of biogenic amines stored in granules (vesicles)? III. A possible role of sodium ions in non-exocytotic fractional release of neurotransmitters. , 1984, Acta physiologica Scandinavica.

[303]  S. Z. Langer,et al.  The amphetamine paradox in dopaminergic neurotransmission , 1984 .

[304]  B. Uvnäs,et al.  Cation exchange--a common mechanism in the storage and release of biogenic amines stored in granules (vesicles)? II. Comparative studies on sodium-induced release of biogenic amines from the synthetic weak cation-exchangers Amberlite IRC-50 and duolite CS-100 and from biogenic (granule-enriched) mat , 1984, Acta physiologica Scandinavica.

[305]  E. Vizi.  Non-synaptic interactions between neurons : modulation of neurochemical transmission : pharmacological and clinical aspects , 1984 .

[306]  E. Vizi.  Non-synaptic modulation of transmitter release: pharmacological implication , 1979 .

[307]  R. Roth,et al.  Dopaminergic neurons: Role of presynaptic receptors in the regulation of transmitter biosynthesis , 1978 .

[308]  Cho Ak,et al.  Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine. , 1976 .

[309]  M. Moskowitz,et al.  Brain H-3-catecholamine metabolism in experimental cerebral ischemia. , 1975, Neurology.

[310]  R. Busto,et al.  Catecholamines in experimental brain ischemia. , 1975, Archives of neurology.

[311]  J. Glowinski.  Properties and Functions of Intraneuronal Monoamine Compartments in Central Aminergic Neurons , 1975 .

[312]  C. Gauchy,et al.  In vivo spontaneous and evoked release of newly synthesized dopamine in the cat caudate nucleus. , 1974, Advances in neurology.

[313]  C. Gauchy,et al.  In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway. , 1973, Naunyn-Schmiedeberg's archives of pharmacology.

[314]  C. Rutledge,et al.  A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain. , 1972, The Journal of pharmacology and experimental therapeutics.

[315]  J. Hubbard.  Mechanism of transmitter release. , 1970, Progress in biophysics and molecular biology.